STIM

#4006
Neuronetics, Inc. Common Stock
1.43 USD
+2.88%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
1.43
1.43
1年のレンジ
0.80
4.82
1日の変化
+2.88%
月次変化
+5.93%
6か月変化
-51.69%
1年の変化
-62.37%
以前の終値
1.39
始値
1.43
Bid
Ask
安値
1.43
High
1.43
ボリューム
29
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 99.07 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.34
売上高対価格比率
0.65

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

ニュース